X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS STERLING BIOTECH DR. DATSONS LABS/
STERLING BIOTECH
 
P/E (TTM) x -10.9 -0.4 - View Chart
P/BV x 0.2 0.0 1,154.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   STERLING BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
STERLING BIOTECH
Dec-13
DR. DATSONS LABS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs12611 1,196.2%   
Low Rs313 908.8%   
Sales per share (Unadj.) Rs133.026.8 496.1%  
Earnings per share (Unadj.) Rs0.2-15.0 -1.0%  
Cash flow per share (Unadj.) Rs6.6-5.5 -121.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.854.9 234.7%  
Shares outstanding (eoy) m31.66267.87 11.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 226.9%   
Avg P/E ratio x516.1-0.5 -111,073.4%  
P/CF ratio (eoy) x11.8-1.3 -930.8%  
Price / Book Value ratio x0.60.1 479.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4771,862 133.1%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m56547 10.2%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m4,2117,181 58.6%  
Other income Rs m7943 184.7%   
Total revenues Rs m4,2897,223 59.4%   
Gross profit Rs m569947 60.0%  
Depreciation Rs m2042,543 8.0%   
Interest Rs m4304,377 9.8%   
Profit before tax Rs m13-5,931 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-1,924 -0.3%   
Profit after tax Rs m5-4,007 -0.1%  
Gross profit margin %13.513.2 102.4%  
Effective tax rate %48.032.4 148.0%   
Net profit margin %0.1-55.8 -0.2%  
BALANCE SHEET DATA
Current assets Rs m6,85214,335 47.8%   
Current liabilities Rs m6,71149,809 13.5%   
Net working cap to sales %3.3-494.0 -0.7%  
Current ratio x1.00.3 354.8%  
Inventory Days Days161403 39.9%  
Debtors Days Days318171 186.6%  
Net fixed assets Rs m3,67355,432 6.6%   
Share capital Rs m317268 118.2%   
"Free" reserves Rs m3,76113,935 27.0%   
Net worth Rs m4,07814,701 27.7%   
Long term debt Rs m1,6719,478 17.6%   
Total assets Rs m12,63373,988 17.1%  
Interest coverage x1.0-0.4 -290.0%   
Debt to equity ratio x0.40.6 63.6%  
Sales to assets ratio x0.30.1 343.4%   
Return on assets %3.40.5 687.5%  
Return on equity %0.1-27.3 -0.4%  
Return on capital %7.7-6.4 -119.4%  
Exports to sales %22.925.9 88.4%   
Imports to sales %14.30.2 8,413.9%   
Exports (fob) Rs m9641,860 51.8%   
Imports (cif) Rs m60212 4,933.6%   
Fx inflow Rs m9641,860 51.8%   
Fx outflow Rs m60725 2,439.1%   
Net fx Rs m3571,835 19.5%   
CASH FLOW
From Operations Rs m1,3451,719 78.2%  
From Investments Rs m-2,256-3,148 71.6%  
From Financial Activity Rs m-1,2001,426 -84.1%  
Net Cashflow Rs m-2,111-3 62,079.4%  

Share Holding

Indian Promoters % 4.5 33.9 13.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 9.9 13.6%  
ADR/GDR % 0.0 16.9 -  
Free float % 94.1 39.3 239.4%  
Shareholders   20,807 21,482 96.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUVEN LIFE  SHASUN PHARMA  SANOFI INDIA  TTK HEALTHCARE  SUN PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, share markets in India witnessed volatile trading activity and ended on a negative note. Among sectoral indices, FMCG stocks and realty stocks lost the most.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS